MiMedx Group Lowers FY2026 Sales Guidance from $260.000M-$290.000M to $250.000M-$260.000M vs $267.018M Est
Benzinga Newsdesk 2 days ago
NewsGuidance
MiMedx Group (NASDAQ:MDXG) lowers FY2026 sales outlook from $260.000 million-$290.000 million to $250.000 million-$260.000 million vs $267.018 million estimate.
MiMedx Group (NASDAQ:MDXG) lowers FY2026 sales outlook from $260.000 million-$290.000 million to $250.000 million-$260.000 million vs $267.018 million estimate.